دورية أكاديمية
أعرض في EDS

Infection-Mediated Clinical Biomarkers for a COVID-19 Electrical Biosensing Platform.

التفاصيل البيبلوغرافية
العنوان: Infection-Mediated Clinical Biomarkers for a COVID-19 Electrical Biosensing Platform.
المؤلفون: Selvarajan RS; Institute of Microengineering and Nanoelectronics (IMEN), National University of Malaysia (UKM), Bangi 43600, Malaysia., Gopinath SCB; Institute of Nano Electronic Engineering (INEE), University Malaysia Perlis (UniMAP), Kangar 01000, Malaysia., Zin NM; Center for Diagnostic, Therapeutic and Investigative Studies, Faculty of Health Sciences, National University of Malaysia (UKM), Kuala Lumpur 50300, Malaysia., Hamzah AA; Institute of Microengineering and Nanoelectronics (IMEN), National University of Malaysia (UKM), Bangi 43600, Malaysia.
المصدر: Sensors (Basel, Switzerland) [Sensors (Basel)] 2021 Jun 01; Vol. 21 (11). Date of Electronic Publication: 2021 Jun 01.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101204366 Publication Model: Electronic Cited Medium: Internet ISSN: 1424-8220 (Electronic) Linking ISSN: 14248220 NLM ISO Abbreviation: Sensors (Basel) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI, c2000-
مواضيع طبية MeSH: Biosensing Techniques* , COVID-19*, Biomarkers ; COVID-19 Testing ; Humans ; Pandemics ; SARS-CoV-2
مستخلص: The race towards the development of user-friendly, portable, fast-detection, and low-cost devices for healthcare systems has become the focus of effective screening efforts since the pandemic attack in December 2019, which is known as the coronavirus disease 2019 (COVID-19) pandemic. Currently existing techniques such as RT-PCR, antigen-antibody-based detection, and CT scans are prompt solutions for diagnosing infected patients. However, the limitations of currently available indicators have enticed researchers to search for adjunct or additional solutions for COVID-19 diagnosis. Meanwhile, identifying biomarkers or indicators is necessary for understanding the severity of the disease and aids in developing efficient drugs and vaccines. Therefore, clinical studies on infected patients revealed that infection-mediated clinical biomarkers, especially pro-inflammatory cytokines and acute phase proteins, are highly associated with COVID-19. These biomarkers are undermined or overlooked in the context of diagnosis and prognosis evaluation of infected patients. Hence, this review discusses the potential implementation of these biomarkers for COVID-19 electrical biosensing platforms. The secretion range for each biomarker is reviewed based on clinical studies. Currently available electrical biosensors comprising electrochemical and electronic biosensors associated with these biomarkers are discussed, and insights into the use of infection-mediated clinical biomarkers as prognostic and adjunct diagnostic indicators in developing an electrical-based COVID-19 biosensor are provided.
References: BMJ. 2003 Jun 21;326(7403):1358-62. (PMID: 12816821)
West Indian Med J. 2014 Sep;63(5):465-9. (PMID: 25781284)
Sensors (Basel). 2021 Feb 13;21(4):. (PMID: 33668579)
Biosens Bioelectron. 2020 Oct 1;165:112349. (PMID: 32510340)
J Res Med Sci. 2014 Feb;19(2):164-74. (PMID: 24778671)
Crit Care. 2020 Jun 23;24(1):373. (PMID: 32576222)
Mikrochim Acta. 2019 Jun 26;186(7):472. (PMID: 31243577)
Biosensors (Basel). 2018 Mar 30;8(2):. (PMID: 29601504)
Sensors (Basel). 2020 Jul 01;20(13):. (PMID: 32630192)
ACS Sens. 2020 Aug 28;5(8):2503-2513. (PMID: 32375472)
Anal Chim Acta X. 2019 Oct 03;3:100029. (PMID: 33117982)
Anal Chim Acta. 2019 May 16;1056:26-33. (PMID: 30797458)
Emerg Infect Dis. 2004 Feb;10(2):311-6. (PMID: 15030703)
Am J Respir Crit Care Med. 1997 Jan;155(1):21-5. (PMID: 9001283)
ACS Nano. 2020 May 26;14(5):5268-5277. (PMID: 32281785)
Faraday Discuss. 2021 Apr 1;227:204-212. (PMID: 33295356)
J Biomark. 2015;2015:519534. (PMID: 26345247)
Analyst. 2020 Jul 13;145(14):5019-5026. (PMID: 32520014)
Mikrochim Acta. 2020 Oct 5;187(11):588. (PMID: 33015730)
Vet Immunol Immunopathol. 1999 Mar 29;68(1):91-8. (PMID: 10231954)
ACS Chem Neurosci. 2020 Jun 17;11(12):1704-1705. (PMID: 32485101)
Biosens Bioelectron. 2018 May 1;104:113-119. (PMID: 29331425)
Eur Respir J. 2020 Oct 1;56(4):. (PMID: 32883678)
Infection. 2020 Oct;48(5):715-722. (PMID: 32734556)
Lancet. 2020 Mar 28;395(10229):1054-1062. (PMID: 32171076)
Front Immunol. 2020 Jun 16;11:1446. (PMID: 32612617)
Clin Infect Dis. 2020 Jul 28;71(15):762-768. (PMID: 32161940)
Int J Antimicrob Agents. 2020 Mar;55(3):105924. (PMID: 32081636)
BMJ Evid Based Med. 2021 Jun;26(3):107-108. (PMID: 32934000)
Science. 2020 May 1;368(6490):473-474. (PMID: 32303591)
Int J Infect Dis. 2020 Jul;96:131-135. (PMID: 32376308)
ACS Nano. 2020 Apr 28;14(4):5135-5142. (PMID: 32293168)
Acta Paediatr Scand. 1983 Nov;72(6):861-6. (PMID: 6673488)
Methods Mol Biol. 2007;382:313-31. (PMID: 18220240)
Front Immunol. 2020 Jul 10;11:1708. (PMID: 32754163)
Biosens Bioelectron. 2020 Sep 15;164:112316. (PMID: 32553350)
Mediators Inflamm. 2015;2015:387842. (PMID: 26424968)
Intensive Care Med. 2020 May;46(5):846-848. (PMID: 32125452)
Biosens Bioelectron. 2018 Jul 1;110:23-37. (PMID: 29579646)
Chest. 2008 Jun;133(6):1302-1311. (PMID: 17989163)
Int J Antimicrob Agents. 2020 Aug;56(2):106051. (PMID: 32534186)
Biosens Bioelectron. 2019 Feb 1;126:543-550. (PMID: 30481668)
Front Pharmacol. 2020 Jun 19;11:937. (PMID: 32636754)
Infect Drug Resist. 2020 Jul 28;13:2609-2615. (PMID: 32801798)
Clin Chem. 2005 Jan;51(1):47-55. (PMID: 15364884)
J Biol Regul Homeost Agents. 2020 Mar 14;34(2):327-331. (PMID: 32171193)
Biosens Bioelectron. 2020 Oct 15;166:112431. (PMID: 32862842)
Metallomics. 2014 Apr;6(4):748-73. (PMID: 24549403)
J Infect. 2020 Sep;81(3):452-482. (PMID: 32526326)
3 Biotech. 2020 Sep;10(9):385. (PMID: 32818132)
Sensors (Basel). 2019 Dec 25;20(1):. (PMID: 31881686)
Data Brief. 2018 Feb 03;17:1288-1294. (PMID: 29845100)
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. (PMID: 32711058)
Sensors (Basel). 2020 May 06;20(9):. (PMID: 32384631)
Hypertension. 2020 Nov;76(5):1339-1349. (PMID: 32851855)
Biosens Bioelectron. 2019 Feb 1;126:806-814. (PMID: 30602262)
J Infect. 2020 Jun;80(6):646-655. (PMID: 32277967)
Clin Med (Lond). 2021 Jan;21(1):e54-e56. (PMID: 33243836)
Sensors (Basel). 2019 Dec 16;19(24):. (PMID: 31888286)
J Infect. 2008 Sep;57(3):249-59. (PMID: 18657324)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
J Med Virol. 2020 Nov;92(11):2283-2285. (PMID: 32343429)
RSC Adv. 2020 Mar 6;10(16):9723-9729. (PMID: 35497247)
Mikrochim Acta. 2019 Feb 2;186(3):153. (PMID: 30712159)
Adv Clin Chem. 2019;90:25-80. (PMID: 31122611)
Sci Rep. 2020 Aug 13;10(1):13689. (PMID: 32792492)
Biosens Bioelectron. 2021 Jan 15;172:112752. (PMID: 33126180)
Int J Antimicrob Agents. 2020 Jun;55(6):105982. (PMID: 32305588)
Nanoscale Res Lett. 2016 Dec;11(1):406. (PMID: 27639579)
Biosensors (Basel). 2020 Aug 05;10(8):. (PMID: 32764518)
Analyst. 2020 Jul 13;145(14):5004-5010. (PMID: 32520017)
Lab Chip. 2019 Aug 7;19(15):2568-2580. (PMID: 31243422)
Biosensors (Basel). 2017 Apr 17;7(2):. (PMID: 28420169)
Acta Clin Belg. 2022 Apr;77(2):268-272. (PMID: 32966166)
Anal Chim Acta. 2020 Feb 8;1097:169-175. (PMID: 31910957)
Lancet. 2020 Mar 28;395(10229):1033-1034. (PMID: 32192578)
Nat Rev Cancer. 2013 Dec;13(12):871-82. (PMID: 24263190)
Lancet. 2020 Feb 15;395(10223):507-513. (PMID: 32007143)
Biosens Bioelectron. 2017 Sep 15;95:100-105. (PMID: 28431362)
Front Immunol. 2020 Sep 02;11:2132. (PMID: 32983172)
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3. (PMID: 32320677)
J Perinatol. 2007 May;27(5):297-302. (PMID: 17344924)
Sens Biosensing Res. 2020 Aug;29:100362. (PMID: 32835001)
Biosens Bioelectron. 2020 Mar 1;151:111979. (PMID: 31999586)
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1506-9. (PMID: 10228118)
معلومات مُعتمدة: AKU 254: HICoE (Fasa II) 'MEMS for Biomedical Devices 617 (artificial kidney)' Ministry of Higher Education, Malaysia
فهرسة مساهمة: Keywords: acute phase proteins; adjunct diagnostic biomarkers; cytokine storm; electrochemical sensors; electronic biosensors; pro-inflammatory cytokines; prognostic indicators
المشرفين على المادة: 0 (Biomarkers)
تواريخ الأحداث: Date Created: 20210702 Date Completed: 20210706 Latest Revision: 20231111
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC8198817
DOI: 10.3390/s21113829
PMID: 34205852
قاعدة البيانات: MEDLINE
الوصف
تدمد:1424-8220
DOI:10.3390/s21113829